Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2025-12-25 @ 12:14 PM
NCT ID: NCT03027661
Description: Reaction to local anesthetic is the main adverse event expected. No adverse reactions were observed.
Frequency Threshold: 0
Time Frame: 30 days from enrollment
Study: NCT03027661
Study Brief: Para-cervical Block Prior to Laparoscopic Hysterectomy as an Adjuvant Treatment to Reduce Postoperative Pain.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Control Group Injection of 10 mL of 0.9% sodium chloride into the cervical stroma divided between 3 and 9 o'clock 0.9% Sodium Chloride: Inject 10 mL of 0.9% NaCl into cervical stroma 0 None 0 20 0 20 View
Study Group Injection of 10 mL of 0.5% bupivacaine into the cervical stroma divided between 3 and 9 o'clock. Bupivacaine: Inject 10 mL of 0.5% bupivacaine into cervical stroma 0 None 0 21 0 21 View
Serious Events(If Any):
Other Events(If Any):